Andrew Hollman Meyer Janux Therapeutics, Inc. (JANX) insider trading activity
Andrew Hollman Meyer is Chief Business Officer of Janux Therapeutics, Inc.. Currently has a direct ownership of 67,592 shares of JANX, which is worth approximately $3.14 Million. The most recent transaction as insider was on Sep 27, 2024, when has been sold 50,000 shares (Common Stock) at a price of $45.96 per share, resulting in proceeds of $2,298,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
67.6K
n/a
3M change
n/a
12M change
Total Value Held
$3.14 Million
Andrew Hollman Meyer Transaction History
AHM
Andrew Hollman Meyer
Chief Business Officer
La Jolla, CA